Get the Stockscreener App
13.45
0.66%
-0.09
Optimizerx Corp stock is traded at $13.45, with a volume of 11,559.
It is down -0.66% in the last 24 hours and down -12.89% over the past month.
OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its product offerings are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.
See More
Previous Close:
$13.54
Open:
$13.52
24h Volume:
11,559
Relative Volume:
0.04
Market Cap:
$281.13M
Revenue:
$62.81M
Net Income/Loss:
$-13.75M
P/E Ratio:
-16.81
EPS:
-0.8
Net Cash Flow:
$153.00K
1W Performance:
+0.15%
1M Performance:
-12.89%
6M Performance:
+150.93%
1Y Performance:
+35.58%
1-Day Range:
$13.28
$13.52
1-Week Range:
$12.88
$13.95
52-Week Range:
$3.78
$15.71
Optimizerx Corp Stock (OPRX) Company Profile
Name
Optimizerx Corp
Sector
Industry
Phone
248-651-6558
Address
260 CHARLES STREET, WALTHAM, MI
Compare OPRX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OPRX
Optimizerx Corp
|
13.40 | 281.13M | 62.81M | -13.75M | 153.00K | -0.80 |
|
VEEV
Veeva Systems Inc
|
283.90 | 46.43B | 2.86B | 780.66M | 1.20B | 4.72 |
|
TEM
Tempus Ai Inc
|
59.28 | 12.01B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
61.75 | 10.79B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
98.80 | 9.27B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
37.50 | 7.03B | 906.14M | -52.62M | 89.62M | -0.3621 |
Optimizerx Corp Stock (OPRX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-08-25 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Dec-20-24 | Initiated | Stephens | Equal-Weight |
| Jul-25-24 | Resumed | B. Riley Securities | Buy |
| Apr-04-24 | Initiated | JMP Securities | Mkt Outperform |
| Jan-03-24 | Initiated | Barclays | Equal Weight |
| Feb-02-23 | Resumed | B. Riley Securities | Buy |
| Nov-01-22 | Initiated | Stifel | Buy |
| Jul-15-22 | Initiated | SVB Leerink | Outperform |
| Oct-18-21 | Resumed | B. Riley Securities | Buy |
| Apr-13-21 | Initiated | RBC Capital Mkts | Outperform |
| Jan-03-19 | Initiated | William Blair | Outperform |
View All
Optimizerx Corp Stock (OPRX) Latest News
Calculating The Fair Value Of OptimizeRx Corporation (NASDAQ:OPRX) - Yahoo Finance
Simulmedia and OptimizeRx Announce Partnership from the Cannes Lions - Business Wire
OptimizeRx Co. (NASDAQ:OPRX) Shares Bought by Bank of America Corp DE - MarketBeat
OptimizeRx Co. (NASDAQ:OPRX) Shares Purchased by Bank of America Corp DE - Defense World
OptimizeRx (NASDAQ:OPRX) Stock Price Expected to Rise, Stifel Nicolaus Analyst Says - MarketBeat
Kalkine : indexnasdaq ixic OptimizeRx Drives Healthcare Tech Communication Shift - Kalkine Media
OptimizeRx (NASDAQ:OPRX) Given New $16.00 Price Target at Stifel Nicolaus - Defense World
OptimizeRx (OPRX) Price Target Raised by Stifel Analyst | OPRX S - GuruFocus
OptimizeRx (OPRX) Price Target Raised by Stifel to $16 | OPRX St - GuruFocus
Stifel raises OptimizeRX stock price target to $16 from $12 By Investing.com - Investing.com South Africa
Stifel raises OptimizeRX stock price target to $16 from $12 - Investing.com
OptimizeRx Co. (NASDAQ:OPRX) Shares Bought by Squarepoint Ops LLC - Defense World
Here's Why OptimizeRx Corp. (OPRX) is a Great Momentum Stock to Buy - sharewise
OptimizeRx Corp (OPRX) Stock Price Up 6.89% on Jun 5 - GuruFocus
New Strong Buy Stocks for June 4th - TradingView
OptimizeRx Co. (NASDAQ:OPRX) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World
Jane Street Group LLC Raises Stock Holdings in OptimizeRx Co. (NASDAQ:OPRX) - Defense World
OptimizeRx Co. (NASDAQ:OPRX) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
BNP Paribas Financial Markets Grows Position in OptimizeRx Co. (NASDAQ:OPRX) - Defense World
Northern Trust Corp Purchases 6,043 Shares of OptimizeRx Co. (NASDAQ:OPRX) - Defense World
OptimizeRx Corp (OPRX) Shares Gap Down to $12.125 on May 28 - GuruFocus
Sherbrooke Park Advisers LLC Sells 22,429 Shares of OptimizeRx Co. (NASDAQ:OPRX) - MarketBeat
D. E. Shaw & Co. Inc. Purchases 32,062 Shares of OptimizeRx Co. (NASDAQ:OPRX) - MarketBeat
OptimizeRx’s SWOT analysis: digital health firm’s stock faces growth hurdles - Investing.com
Tang Capital Management LLC Invests $1.08 Million in OptimizeRx Co. (NASDAQ:OPRX) - MarketBeat
AWM Investment Company Inc. Has $1.05 Million Stake in OptimizeRx Co. (NASDAQ:OPRX) - MarketBeat
D. E. Shaw & Co. Inc. Raises Position in OptimizeRx Co. (NASDAQ:OPRX) - Defense World
Earnings Estimates Rising for OptimizeRx (OPRX): Will It Gain? - sharewise
Dimensional Fund Advisors LP Boosts Stake in OptimizeRx Co. (NASDAQ:OPRX) - MarketBeat
OptimizeRx Corp. (OPRX) Beats Q1 Earnings and Revenue Estimates - MSN
OptimizeRx Corp (OPRX) Stock Price Up 4.11% on May 19 - GuruFocus
JMP Securities Increases OptimizeRx (NASDAQ:OPRX) Price Target to $14.00 - MarketBeat
OptimizeRx Corp (OPRX) Shares Up 5.92% on May 16 - GuruFocus
OptimizeRx to Participate in Upcoming Investor Conferences - The Manila Times
OptimizeRx Sets Ambitious Investor Relations Schedule: 4 Major Conferences Including William Blair and B. Riley - Stock Titan
JMP Securities Raises OptimizeRx (NASDAQ:OPRX) Price Target to $14.00 - Defense World
Dimensional Fund Advisors LP Raises Stock Holdings in OptimizeRx Co. (NASDAQ:OPRX) - Defense World
G2 Investment Partners Management LLC Sells 109,041 Shares of OptimizeRx Co. (NASDAQ:OPRX) - MarketBeat
OptimizeRx (OPRX) Price Target Raised by B. Riley Amid Strong Q1 Performance | OPRX Stock News - GuruFocus
OptimizeRx First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
OptimizeRx (OPRX) Price Target Boosted to $22 by Roth Capital | - GuruFocus
Barclays PLC Boosts Stake in OptimizeRx Co. (NASDAQ:OPRX) - Defense World
Wells Fargo & Company MN Purchases 2,797 Shares of OptimizeRx Co. (NASDAQ:OPRX) - Defense World
OptimizeRx Co. (NASDAQ:OPRX) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
OptimizeRx (OPRX) Stock Target Price Raised by JMP Securities | - GuruFocus
OptimizeRX stock target raised to $14 by JMP Securities - Investing.com Nigeria
OPTIMIZERx earnings beat by $0.20, revenue topped estimates - Investing.com Canada
Optimizerx Corp Stock (OPRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Optimizerx Corp Stock (OPRX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Silvestro Stephen L | Chief Commercial Officer |
Mar 01 '25 |
Option Exercise |
0.00 |
1,928 |
0 |
121,886 |
| Odence-Ford Marion | Chief Legal Officer & CHRO |
Mar 01 '25 |
Option Exercise |
0.00 |
771 |
0 |
70,544 |
| KLEMA CATHY | Director |
Feb 02 '25 |
Option Exercise |
0.00 |
5,109 |
0 |
11,752 |
| Odence-Ford Marion | General Counsel and CCO |
Dec 19 '24 |
Option Exercise |
0.00 |
3,927 |
0 |
28,383 |
| Silvestro Stephen L | Chief Commercial Officer |
Dec 19 '24 |
Option Exercise |
0.00 |
6,546 |
0 |
83,424 |
| Besch Doug | Chief Product Officer |
Dec 19 '24 |
Option Exercise |
0.00 |
1,964 |
0 |
12,160 |
| Stelmakh Edward | CFO/COO |
Dec 19 '24 |
Option Exercise |
0.00 |
5,237 |
0 |
38,603 |
| FEBBO WILLIAM J | CEO |
Dec 12 '24 |
Buy |
5.01 |
20,000 |
100,220 |
601,253 |
| Odence-Ford Marion | General Counsel and CCO |
Nov 08 '24 |
Option Exercise |
0.00 |
1,785 |
0 |
24,980 |
| Stelmakh Edward | CFO/COO |
Oct 11 '24 |
Option Exercise |
0.00 |
8,222 |
0 |
35,432 |
0.54%
1.44%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):